| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,601 |
2,123 |
$83K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,274 |
1,927 |
$61K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,332 |
912 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
263 |
231 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
272 |
237 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
56 |
50 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
263 |
225 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,423 |
1,191 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
196 |
169 |
$822.65 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17 |
12 |
$549.36 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
40 |
29 |
$406.76 |
| 90688 |
|
18 |
18 |
$134.07 |
| 80306 |
|
14 |
13 |
$128.10 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
94 |
73 |
$106.82 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$69.15 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
231 |
199 |
$63.72 |
| 80305 |
|
15 |
14 |
$47.06 |
| 81002 |
|
14 |
14 |
$14.34 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
16 |
13 |
$11.43 |